Research [ASAP] An All-in-One Attack: Microneedle-Delivered Bio-Hybrid Nanoagonist for Tumor Immunotherapy LikeLiked Date: April 27, 2026 Less than 1 MinRead Views: 5 ACS Applied Bio Materials DOI: 10.1021/acsabm.6c00180 Source: http://dx.doi.org/10.1021/acsabm.6c00180 Tags:Materials Industry FacebookTwitterLinkedinWhatsAppTelegramEmail ALT-Lab-Ad-1ALT-Lab-Ad-2ALT-Lab-Ad-3ALT-Lab-Ad-4ALT-Lab-Ad-5ALT-Lab-Ad-6ALT-Lab-Ad-7ALT-Lab-Ad-8ALT-Lab-Ad-9ALT-Lab-Ad-10ALT-Lab-Ad-11ALT-Lab-Ad-12ALT-Lab-Ad-13 Recent Articles Mapped: Health Care Costs as a Share of Income by State Finance & investments June 4, 2026 Start process towards Food-Grade Caleyda Materials & Chemicals June 4, 2026 Europe’s Tech Sovereignty Act: A Revolution for Digital Autonomy and Economic Resilience Finance & investments June 4, 2026 🌍 ESG Weekly Brief | Sovereignty, Sustainable Finance & The New Rules of Competitive Advantage Finance & investments June 4, 2026 Diseases cost North American corn growers 11 figures in four years Food & Agriculture June 4, 2026 Atomic Precision Helps Scientists Tailor Thin MXenes for Space Systems Research June 4, 2026 4D Technology Introduces 4Di InSpec™ SR System for Shop-Floor Surface Roughness Research June 4, 2026 Cl radical-mediated electrochemical site-selective functionalization of cysteine residues in NaCl aqueous media Research June 4, 2026 Deep eutectic solvents regulate lignin properties: in situ synthesis of low-curing-temperature phenolic resin Research June 4, 2026 A Moonlit Earth as Seen From Artemis II Research June 4, 2026 Load more
